Aurobindo Pharma has informed that it enclosed the copies of notice for the attention of equity shareholders of the Company published on Thursday, November 27, 2025 in Business Standard and Nava Telangana (Telugu) in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF), in accordance with the requirements of Section 124(6) of the Companies Act, 2013 read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
The above information is a part of company’s filings submitted to BSE.
